HOMEPRODUCTSCOMPANYCONTACTFAQResearchDictionaryPharmaSign Up FREE or Login

Analysis of miRNA-mRNA network reveals miR-140-5p as a suppressor of breast cancer glycolysis via targeting GLUT1.

Abstract
Aim: Aerobic glycolysis is characteristic of breast cancer. Comprehensive expression profiles of key proteins, their prognosis and detailed relationships between miRNAs and mRNAs remain unclear. Materials & methods: Oncomine database, Kaplan-Meier overall survival and miRNA-mRNA network analysis were performed. A key miRNA was identified and explored in vitro and in vivo. Results & conclusion: Eleven key glycolytic proteins were found with higher expression and poor prognosis: GLUT1, SLC2A5, HK1, PFKP, ALDOA, TPI1, GAPDH, PGK1, ENO1, GOT1 and GOT2. Seven miRNAs were predicted targeting 11 key glycolytic proteins: miR-140-5p, miR-3064-5p, miR-152-3p, miR-449b-5p, miR-449a, miR-194-5p and miR-34a-5p. Among them, miR-140-5p was found to be downregulated in breast cancer and directly targeted GLUT1, resulting in an antiglycolytic and antiproliferative effect.
AuthorsYunjie He, Fei Deng, Shujie Zhao, Shanliang Zhong, Jianhua Zhao, Dandan Wang, Xiu Chen, Jian Zhang, Junchen Hou, Wei Zhang, Li Ding, Jinhai Tang, Zuomin Zhou
JournalEpigenomics (Epigenomics) Vol. 11 Issue 9 Pg. 1021-1036 (07 2019) ISSN: 1750-192X [Electronic] England
PMID31184216 (Publication Type: Journal Article, Research Support, Non-U.S. Gov't)
Chemical References
  • Biomarkers, Tumor
  • Glucose Transporter Type 1
  • MicroRNAs
  • Mirn140 microRNA, human
  • RNA, Messenger
  • SLC2A1 protein, human
Topics
  • Biomarkers, Tumor (genetics)
  • Breast Neoplasms (diagnosis, genetics)
  • Cell Line, Tumor
  • Cell Proliferation
  • Down-Regulation
  • Female
  • Glucose Transporter Type 1 (genetics)
  • Glycolysis (genetics)
  • Humans
  • MicroRNAs (genetics)
  • Prognosis
  • RNA, Messenger (genetics)

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.
Realize the full power of the drug-disease research graph!


Choose Username:
Email:
Password:
Verify Password:
Enter Code Shown: